Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
摘要
<p>Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.</p>
申请公布号
AU2012274215(B2)
申请公布日期
2015.12.10
申请号
AU20120274215
申请日期
2012.06.15
申请人
MEDIGENEBIO CORPORATION;GREEN CROSS CORPORATION
发明人
JIN, THONG-GYU;CHUNG, YO KYUNG;PAIK, SANG HOON;PARK, YOO CHANG;SEO, JINWOOK;CHOI, YONG WOON;SON, JONG MUN;KIM, YONG-CHUL